Special Clinical Focus
- Benign and malignant conditions
- Malignant tumors
- Gynecological conditions and tumors
Dr. György Lövey is a specialist in oncological radiotherapy in Bottrop. At the Radiotherapy Practice in the Specialist Center at the Miners’ Association Hospital in Bottrop, he and his team provide treatment techniques at the cutting edge of science and technology. Together with surgery and chemotherapy, the oncological radiotherapy utilized by Dr. Lövey forms one of the three main pillars in the treatment of malignant tumors. Here, the radiotherapy specialist, Dr. Lövey, schedules a treatment strategy for each patient individually. In deciding the respective treatment method, he takes previous conditions, the current diagnosis and the patient’s general condition into consideration, and thus makes a therapeutic plan personally tailored to each patient possible. At the radiotherapy practice in the Specialist Center at the Miners’ Association Hospital in Bottrop, newly opened in 2018, a state-of-the-art linear accelerator, an Elekta Versa HD with Agility radiation head, supports the treatment of benign and malignant conditions by means of percutaneous radiotherapy (from the Latin per, “through” and cutis, “skin”). Thanks to 160 0.5 cm wide tungsten lamellae (MLC, multi-lamella collimator), the equipment enables the optimal coverage of the target region specified by Dr. Lövey. Together with conformal radiotherapy with fixed fields, the modulation techniques IMRT (Intensity Modulated Radiotherapy) and VMAT (Volume Modulated Arc Therapy) are also employed here. The linear accelerator provides an integrated ConeBeam CT (CBCT) in order to verify the patient’s positioning. The radiotherapy practice in Bottrop also possesses radiotherapy equipment for HDR brachytherapy, a Flexitron by the Nucletron company. The specialists utilize this for radiotherapy for suitable patients in the treatment of gynecological tumors. Here, the specialist introduces an applicator vaginally into the patient. The applicator serves as the guide for a radioactive source, which is inserted into the applicator for the period of the radiotherapy treatment. This applies the dose determined by Dr. Lövey and is then removed again. Thanks to this special technique, the radiotherapy is applied directly to the diseased site and not from outside, through the skin. Patients can leave the practice entirely normally following treatment. In collaboration with the Marien Hospital in Bottrop and the Elisabeth Hospital in Oberhausen, Dr. Lövey provides a further radiotherapy technique, in which the radiotherapy is also not given through the skin. Patients with breast cancer can be given targeted irradiation to the tumor site by means of a further variant of brachytherapy, IORT (intraoperative radiotherapy). For the optimal treatment result, the tumor bed (the tissue surrounding the tumor) is irradiated following the removal of the tumor. This radiotherapy technique is particularly comfortable for the patients since they remain under anesthetic. Unfortunately, for some patients, various factors militate against this radiotherapy technique. Here, the radiotherapy specialist will decide in favor of a percutaneous irradiation of the tumor bed following the treatment of the affected breast, by means of teletherapy using the linear accelerator.
MRgFUS Center in Bottrop.
A further technique for radiological tumor therapy is so-called MRgFUS (magnetic resonance imaging-guided high-focus ultrasound), an innovative and particularly gentle technique for the treatment of uterine myomata. Thanks to the unique combination of high-intensity ultrasound waves (for the therapy) and magnetic resonance imaging (for the planning, guidance and monitoring), the attending physician can continually monitor and optimize the treatment in real time. Thanks to this form of non-invasive treatment, Dr. Lövey and his team at the FUS in Bottrop can treat uterine myomata without surgery. As a medical sectional imaging technique, the use of magnetic resonance imaging (MRI) enables targeted treatment and temperature monitoring in real time. By concentrating ultrasound waves inside the body, the myoma can be heated with precision to the millimeter, point by point. Temperatures of between 60 and 90 degrees Celsius are generated here. The surrounding tissue remains untouched. The myoma tissue is destroyed by the heat build-up; the myoma shrivels and no longer causes any discomfort. In the months to follow, the body’s own immune system breaks down the remnants to a large extent. Whether treatment with MRgFUS is possible can only be determined by means of an MRI examination performed in the treatment position (prone position). With the aid of the MRI imaging, Dr. Lövey identifies the number, location, size and circulation activity of the myomata and, on this basis, can assess the treatability with MRgFUS. We would be happy to arrange the required appointment via our Patient Management.
Please contact us on:
telephone: +49 2041 5669001